Omega-3 and Postpartum Mood in the First Months

Short answer: Omega-3 fatty acids, especially DHA, are structural components of the brain and play a role in the signaling systems that affect mood. However, the evidence that omega-3 supplements specifically improve postpartum mood is currently rated insufficient by the NIH, meaning well-designed research has not yet confirmed a clear benefit. Speaking with a clinician is the most important step any new parent can take for postpartum mental health support.

Why Omega-3s Come Up in Postpartum Conversations

After birth, many parents notice that conversations about nutrition quickly turn to omega-3 fatty acids. The interest is not random. According to the NIH Office of Dietary Supplements (ODS), DHA is especially concentrated in the brain and retina, where it serves as a structural component of cell membrane phospholipids. Because a developing fetus draws heavily on maternal DHA stores during the third trimester, some researchers have hypothesized that postpartum DHA depletion could affect mood regulation in new parents. This is a reasonable hypothesis to study, but a hypothesis is not the same as a proven treatment.

What Omega-3 Fatty Acids Actually Do in the Body

The NIH ODS identifies three main physiological roles for omega-3 fatty acids:

• Structural support: They are components of the phospholipids that form cell membranes throughout the body, with DHA found in especially high concentrations in the brain, retina, and sperm. This role is supported by strong evidence.
• Energy supply: Like other dietary fats, omega-3s provide a source of energy for the body.
• Precursors to eicosanoids: Omega-3s act as precursors to eicosanoids, signaling molecules involved in cardiovascular, pulmonary, immune, and endocrine function. These molecules influence inflammation and other wide-ranging biological processes.

Because mood regulation involves complex brain chemistry and immune signaling, researchers have explored whether optimizing omega-3 intake could support emotional wellbeing after birth. The connection is biologically plausible, but plausibility alone does not establish that a supplement will produce a clinical benefit.

What the Evidence Actually Shows

The NIH ODS uses a graded evidence framework. For omega-3 supplements and mood or brain health, the ratings are sobering:

• The claim that omega-3 supplements prevent cognitive decline, dementia, or Alzheimer disease is rated insufficient by the NIH ODS, meaning current research does not confirm a benefit.
• The claim that DHA supplementation during pregnancy or infancy improves infant neurodevelopment or visual development is also rated insufficient.
• By contrast, the role of DHA and EPA as structural brain components is supported by strong evidence, and the ability of long-chain omega-3 supplements to lower elevated triglycerides is rated moderate.

There is no separate NIH ODS evidence rating specifically for omega-3 supplements and postpartum mood disorders. Studies in this area are ongoing, but none have produced findings strong enough to shift the overall evidence rating above insufficient. New parents searching for peer-reviewed research will find small trials with mixed results rather than a settled scientific consensus.

This does not mean omega-3s are useless during the postpartum period. Adequate nutrition, including sufficient dietary fat, supports overall health at a demanding time. It means that omega-3 supplements should not be positioned as a treatment for postpartum depression or anxiety, and that anyone experiencing mood symptoms should seek professional care rather than relying on a supplement.

Supplements are not intended to diagnose, treat, cure, or prevent any disease, and these statements have not been evaluated by the FDA.

Intake Reference Values

The NIH ODS reports the following reference values from the Institute of Medicine (now the National Academies of Sciences, Engineering, and Medicine). These figures apply to the general adult population and are expressed as Adequate Intake (AI) values for alpha-linolenic acid (ALA), the essential plant-based omega-3:

• Women ages 19 to 50: 1.1 g per day of ALA
• Men ages 19 to 50: 1.6 g per day of ALA

Importantly, no Recommended Dietary Allowance (RDA) has been established for omega-3s because the data were insufficient for the IOM to set an Estimated Average Requirement (EAR), which is a prerequisite for an RDA. There is also no specific intake recommendation for EPA or DHA as individual nutrients. No Tolerable Upper Intake Level has been set for any omega-3 fatty acid by the IOM.

For supplement labels specifically, the FDA specifies that a daily intake of EPA and DHA from supplements should not be recommended at more than 2 g per day. This is a labeling guideline, not a clinical dose recommendation. Personal dosing decisions should be made with a clinician or pharmacist who knows your full health picture, including pregnancy or breastfeeding status.

Safety and Side Effects

According to the NIH ODS, omega-3s from food and supplements are generally regarded as safe. Side effects from supplements are usually mild and may include an unpleasant taste, bad breath, bad-smelling sweat, headache, heartburn, nausea, stomach discomfort, or diarrhea. Taking supplements with food often reduces these effects.

At higher doses, roughly 900 mg per day of EPA plus 600 mg per day of DHA or more sustained over several weeks, omega-3s may suppress inflammatory immune responses and could reduce immune function. Prescription high-dose omega-3 products used to lower triglycerides are drug-strength doses and should be used only under medical supervision.

Drug and Supplement Interactions

This section is especially relevant for postpartum individuals who may be taking other medications. Because omega-3 fatty acids can reduce platelet aggregation and prolong bleeding time, combining them with anticoagulant or antiplatelet medications may theoretically increase bleeding risk. Medications in this category include warfarin, aspirin, and clopidogrel, as well as certain herbs and supplements with blood-thinning properties.

The NIH ODS notes that clinical trials have generally shown that any prolongation of bleeding time did not exceed normal limits or cause clinically significant bleeding. Even so, periodic monitoring is advised. Always talk to a doctor or pharmacist before combining omega-3 supplements with any medication.

Practical Takeaways for New Parents

• Omega-3s have well-established structural roles in the brain, but evidence that supplements improve postpartum mood is currently insufficient.
• Dietary sources such as fatty fish, walnuts, and flaxseed can help meet the AI for ALA without the need for supplements.
• If you are considering a supplement, discuss the appropriate form and amount with your clinician, especially if you are breastfeeding or taking other medications.
• Postpartum mood changes are common and can range from mild to serious. A supplement is not a substitute for professional mental health support. If you are struggling, contact your healthcare provider promptly.

Sources

NIH Office of Dietary Supplements, Omega-3 Fatty Acids Fact Sheet for Health Professionals and Consumer fact sheet (ods.od.nih.gov). National Center for Complementary and Integrative Health, Omega-3 Supplements: What You Need to Know (nccih.nih.gov). National Academies of Sciences, Engineering, and Medicine, Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (nap.nationalacademies.org/catalog/10490).